A study to measure and evaluate the levels of complements and albumin in chronic obstructive pulmonary disease

Study on the levels of complements and albumin in chronic obstructive pulmonary disease

Status

Active, not recruiting

Phases

Phase 4

Study type

Observational

Source

CTRI

Registry ID

CTRI/2017/10/010111

Enrollment

150

Registered

2017-10-16

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Chronic Obstructive Pulmonary Disease

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: Patients willing to participate in the study

Exclusion criteria

Exclusion criteria: Patients not willing to participate in the study Patients aged 65 years Patients with immunological disorders that might interfere with complement activation (systemic lupus erythematosus, rheumatoid arthritis, allergy, and neoplasms) Patients unable to perform Pulmonary Function Tests (PFT) Pregnancy Patients having known Liver Diseases/Renal Diseases/Diabetes Mellitus/T.B. Patients taking drugs that affect albumin level like anabolic steroids, androgens, growth hormone, insulin

Design outcomes

Primary

Measure	Time frame
To study and compare the levels of complement C3, C4 and albumin found in chronic obstructive pulmonary disease patients with healthy controlsTimepoint: 1 year	—

Secondary

Measure	Time frame
To study the levels of complement C3, C4 and albumin found in chronic obstructive pulmonary disease patients and correlate them with severity of diseaseTimepoint: 1 year	—

Countries

India

Contacts

Public ContactDr Chirag K Pandya

Government Medical College Bhavnagar

hariom_sharma2000@yahoo.com

Outcome results